Time: 2024-07-09
The United States has seen a rise in the Deep Brain Stimulation ( DBS ) market for Parkinson 's Disease , with a projected growth rate of 7.10 % by 2029 . The increasing prevalence of Parkinson 's Disease among the aging population , along with advancements in medical technology , is driving this growth . DBS has shown positive results in managing the motor symptoms of Parkinson 's Disease , improving the quality of life for patients . Technological advancements have led to the development of less invasive DBS devices and streamlined procedures , increasing patient acceptance and market demand.
DBS is not limited to Parkinson 's Disease , as its clinical applications are expanding to include other neurological and neuropsychiatric disorders such as essential tremor , dystonia , obsessive - compulsive disorder , and epilepsy . This expansion creates new opportunities for the use of DBS , widening its reach and fostering market growth . The robust healthcare infrastructure in the United States , along with improved access to specialized care and insurance coverage , plays a crucial role in more patients opting for DBS therapy . However , challenges such as limited awareness , high treatment costs , and disparities in access to specialized care still exist.
With an increasing range of clinical indications for DBS , there is a shift towards minimally invasive devices and closed - loop systems that adapt to patients ' needs in real - time , focusing on patient - centered outcomes . This trend , along with enhancements in technology and a greater emphasis on patient quality of life , is driving the adoption of DBS . The positive outlook for the deep brain stimulation market in Parkinson 's Disease reflects the industry 's dynamism and alignment with medical innovation and patient care excellence . As the United States advances its neurological healthcare services , DBS therapy is expected to reach new heights.
The global deep brain stimulation market is projected to reach .56 billion by 2029 , growing at a CAGR of 11.89 % . Key drivers for market growth include the rise in the geriatric population , increasing prevalence of neurological disorders , expanding indications for DBS , and growing healthcare infrastructure . However , challenges such as potential side effects , high treatment costs , and presence of alternative procedures may hinder market growth . The market is driven by trends like telemedicine , automated DBS , closed - loop systems , and rechargeable devices with longer battery life , tapping into emerging markets and miniaturized DBS devices.
Overall , the market for deep brain stimulation is witnessing significant growth and diversification in both the United States and globally , with innovative technologies and expanding clinical applications driving advancements in neurological care for patients with various disorders . Companies like Boston Scientific , Medtronic , and Abbott Laboratories are playing a key role in shaping the future of DBS therapy and contributing to the growth of the market.
Business
